RENyTe is derived from the Wharton’s Jelly of the umbilical cord. Wharton’s Jelly is a clear gel-like tissue that contains up to fifty times more hyaluronic acid and growth factors than amniotic fluid, further increasing regenerative success. These higher concentrations of growth factors have been shown to prevent cell death.
RENyTe is recovered from healthy, carefully screened mothers at the time of delivery and processed in accordance with FDA and AATB (American Association of Tissue Banks) regulations and standards. Many patients have chosen RENyTe over other similar regenerative treatments to help promote the body’s natural ability to heal.